Abstract
Purpose
Intramedullary spinal cord abnormalities are often challenging to diagnose. Spinal cord biopsy is a high-risk procedure with the potential to cause permanent neurological injury. Magnetic resonance imaging is the modality of choice for diagnosis and preoperative assessment of patients with spinal cord abnormalities. The radiologist’s ability to narrow the differential diagnosis of spinal cord abnormalities has the potential to save patients from invasive approaches for diagnosis and also guide appropriate management.
Approach/methods
This article will provide a systematic approach to the evaluation of intramedullary spinal cord lesions—with emphasis on location, length and segment distribution, and enhancement pattern—to help narrow the differential diagnosis. In doing so, we will review various spinal cord pathologies, including demyelinating and metabolic conditions, neoplasms, and vascular lesions.
Summary/conclusion
Although intramedullary spinal cord abnormalities can be a challenge for the radiologist, a systematic approach to the differential diagnosis with a focus on lesion location, cord length and segment involvement, as well as enhancement pattern, can greatly help narrow the differential diagnosis, if not synch the diagnosis. This strategy will potentially obviate the need for an invasive approach to diagnosis and help guide treatment.
Teaching points
• Imaging diagnosis of intramedullary spinal cord lesions could obviate cord biopsy.
• Evaluation of cord lesions should focus on location, length, and enhancement pattern.
• In demyelination, the degree of cross-sectional involvement is a distinguishing feature.
Keywords: Spinal cord, Demyelinating diseases, Spinal neoplasms, MR, Review
Introduction
Intramedullary spinal cord abnormalities are a diagnostic challenge. Spinal cord biopsy is a high-risk procedure with potential to cause permanent neurological injury [1]. Magnetic resonance imaging (MRI) is the modality of choice for diagnosis and preoperative assessment of patients with spinal cord abnormalities. The radiologist’s ability to narrow the differential diagnosis of spinal cord abnormalities has the potential to save patients from invasive approaches to diagnosis and guide appropriate management. This article will provide a systematic approach for the evaluation of intramedullary spinal cord lesions to help narrow the differential diagnosis, if not synch the diagnosis.
Knowledge of spinal cord anatomy is essential for thorough evaluation. The spinal cord extends caudally from the brainstem to the conus medullaris at about the L1–L2 vertebral level. It consists of 31 levels, which are divided into the cervical (8 nerve roots), thoracic (12 nerve roots), lumbar (5 nerve roots), sacral (5 nerve roots), and coccygeal (1 nerve root) levels where nerve roots emerge. As within the brain, the spinal cord is covered by three layers of the meninges: the outer dura mater, middle arachnoid mater, and inner pia mater. Intramedullary anatomy consists of white matter in the form of myelinated ascending and descending fibres and includes the anterior ascending pain and temperature sensory fibres of the spinothalamic tracts, dorsal columns containing ascending vibration and proprioception fibres, and lateral columns, which contain the descending corticospinal tract fibres (Fig. 1). The central grey matter consists of anterior horns containing motor neurons that synapse with the descending corticospinal tract fibres and posterior horns, which are composed of sensory neurons that synapse with ascending sensory fibres [2, 3]. Spinal pathology can be divided into three general categories based on spatial localization: the extradural space, intradural-extramedullary space, and intramedullary space. This article will focus on pathology within the intramedullary space.
Differentiating intramedullary pathology can be challenging given the spinal cord’s morphology and surrounding osseous and ligamentous structures. However, with the advent of MRI, the differential diagnosis can be narrowed by careful analysis of the pattern of involvement, with particular attention given to the location, length, and enhancement pattern. Transverse location, for example, is important to consider when differentiating demyelinating processes (Fig. 2), while location along the cord can help narrow tumor diagnoses. Segmental length of involvement (Fig. 3) can be helpful in differentiating demyelinating processes or help distinguish between neoplastic and vascular lesions. Lastly, presence of multiplicity and the pattern of enhancement should be considered.
Demyelination
Multiple sclerosis
In demyelinating conditions, the underlying mechanism of myelopathy is that of inflammation damaging myelin sheath-forming cells. This can be primary, due to conditions such as multiple sclerosis (MS), or secondary, such as in post-infectious acute disseminated encephalomyelitis (ADEM) or transverse myelitis secondary to underlying viral infection [4]. MS is a primary demyelinating disease affecting the central nervous system with intracranial and spinal involvement (Figs. 4 and 5). The disease is twice as common in females and tends to occur in geographical regions farther away from the equator. MRI is the most important modality in both the diagnosis and clinical management of MS, demonstrating characteristic callososeptal and periventricular, perivenular demyelinating lesions in the brain [5]. Spinal cord involvement of MS frequently occurs along with brain involvement, although isolated spinal cord lesions can occur in 25% of patients. In Asian populations, who are more likely to present with the optic-spinal variant of MS, spinal cord involvement occurs more frequently, and the cord should be carefully evaluated in this subset of the population [6].
Neuromyelitis optica spectrum disease (NMOSD)
NMOSD (also known as Devic’s disease) is a relapsing disease with the typical triad of optic neuritis, myelitis, and positive NMO-IgG, an autoantibody to the protein channel aquaporin-4 (AQP4), which is expressed on foot processes of astrocytes (Fig. 6). The underlying pathophysiology is of autoimmune astrocytopathy [7], distinguishing this condition from MS and other demyelinating processes. The condition is much more common in females (5:1), and brain lesions are shown to occur much more frequently than previously thought. Among other diagnostic criteria, presence of longitudinally extensive spinal cord lesions (LESCL), which are characterised by T2 hyperintense signal of the cord traversing at least three vertebral body levels, is key to its diagnosis [8, 9].
Acute disseminated encephalomyelitis
ADEM is an acute, often monophasic post-infectious or inflammatory condition that most commonly occurs in children (Fig. 7). ADEM can involve both white and grey matter, and although it can demonstrate periventricular brain lesions similar to MS, it is more likely to have ill-defined, larger, and more rounded lesions, with a predilection for deep grey matter and the brainstem [10, 11]. Involvement of the brainstem and spinal cord occurs in approximately one-third of patients with ADEM and its spinal characteristics are helpful in differentiating this condition from MS [5].
Guillain-Barré syndrome
Guillain-Barré syndrome (GBS) can be thought of as the peripheral nervous system counterpart to ADEM, with a post-infectious/inflammatory autoimmune pathophysiology (Fig. 8). It typically involves multiple peripheral nerves, most commonly the anterior nerve roots arising at the cauda equina. The classic clinical history consists of ascending weakness, which can progress to ascending paralysis, typically occurring after a bout of infection or after having received a vaccination. Most cases resolve within a few weeks without residual symptoms [12, 13].
Transverse myelitis
Transverse myelitis is an inflammatory condition of the spinal cord with various underlying aetiologies. This condition may occur at any age; however, it is more common in younger patients. It typically presents with rapidly progressive bilateral sensory and motor dysfunction with a distinct cord level. Approximately one-third of affected patients recover fully while the remaining 60 % will have either moderate or profound neurological deficits. There are various underlying aetiologies of transverse myelitis, including MS, systemic autoimmune disorders such as systemic lupus erythematosus, vascular infarct, post-radiation, post-infectious, or idiopathic. MRI demonstrates a long segment T2 hyperintense cord lesion with bilateral cord involvement, occupying at least two-thirds of the cross-sectional area of the cord (Fig. 9) [14, 15].
HIV myelopathy
HIV myelopathy is a late-onset complication of HIV (Fig. 10). Patients present with insidious onset myelopathy with lower extremity weakness and sensory abnormalities, impotence, and/or urinary symptoms. On MRI, spinal cord atrophy is typically present. Other findings can be seen, including symmetric dorsal column hyperintensity on T2-weighted images similar to subacute combined degeneration, though typically the signal abnormality is limited to the thoracic spine [16, 17]. The cervical spine is involved less commonly. On histology, there is vacuolization of the myelin-forming cells of the spinal cord [17].
Distinguishing demyelinating conditions
In differentiating spinal demyelinating processes, the location along the spine and degree of transverse cord involvement can be distinguishing features. In MS, lesions are more commonly located within the cervical spine and are often multifocal and asymmetric, involving a partial cross-sectional area of the cord, for example, involving a lateral or posterior aspect of the cord on an axial slice. This is in contrast to NMOSD and transverse myelitis, where there is central or more diffuse cord involvement on axial images [6]. MS lesions involve short segments (1–2 vertebral bodies), whereas in NMOSD, long segment and central involvement is more characteristic [11]. MS lesions appear more homogeneous, whereas NMOSD lesions tend to be more ill defined and heterogeneous in T2 hyperintensity [5]. ADEM will demonstrate diffuse T2 hyperintensity and expand the spinal cord; a long segment is commonly involved, and there is no enhancement [18]. If myelopathy is isolated to the conus medullaris/cauda equina, one must consider GBS, in which there is nerve root enhancement, particularly involving the anterior nerve roots [11]. Enhancing lesions in the cord may be seen with active demyelination in MS and NMOSD. The pattern of enhancement is variable with transverse myelitis, while ADEM lesions most commonly do not enhance. Ring-enhancing lesions, which are characteristically seen with tumefactive MS in the brain, can also rarely be present in the spinal cord. In NMOSD, a distinctive ‘lens-shaped’ pattern of enhancement on sagittal images is characteristic if present [18] (Table 1).
Table 1.
Demyelinating diseases | Location | Length and segment distribution | Enhancement |
---|---|---|---|
Multiple sclerosis | Dorsal or lateral columns | Short segment, scattered | Yes, if active |
NMOSD (Devic’s disease) | Central | Long segment | Patchy |
ADEM | Diffuse swelling of cord | Long segment | None |
Guillian-Barré | Diffuse Nerve roots |
Conus medullaris, cauda equina roots | Yes |
Transverse myelitis | > 2/3 on axial view; swelling of cord | Short (acute partial) or long (acute complete) | Variable |
Metabolic conditions
Subacute combined degeneration is the most common manifestation of metabolic derangements within the spinal cord. The condition presents clinically with loss of vibration and proprioception in the extremities, eventually leading to gait ataxia and extremity muscle weakness. The aetiology may be due to copper deficiency (Fig. 11) or nitric oxide use; however, the most common aetiology is vitamin B12 deficiency (Fig. 12). On MRI, the characteristic pattern is of long segment T2 hyperintensity involving the posterior spinal cord, classically involving the dorsal columns and producing a characteristic reversed “V” sign [19, 20] (Table 2).
Table 2.
Metabolic | Location | Length and segment distribution | Enhancement |
---|---|---|---|
Subacute combined degeneration • Vitamin B12 deficiency • Copper deficiency • Nitric oxide inhalation |
Dorsal columns | Long segment | None |
Neoplasms
Ependymoma
Ependymomas are benign glial tumors that arise from ependymal cells lining the brain’s ventricles or the central canal of the spinal cord (Fig. 13). Although the majority of ependymomas occur intracranially, about 10% occur in the spinal cord and represent the most common intramedullary spinal cord tumor in adults. Spinal ependymomas most commonly occur in the cervical cord, though they can occur anywhere along the spinal cord. The myxopapillary subtype is confined to the filum terminale with rare extension into the conus medullaris. Their association with neurofibromatosis type II is explained by abnormality found within chromosome 22; the NF2 gene is located on chromosome 22q and patients with an ependymoma often have defects on the same chromosome [21–24].
Hemangioblastomas
Hemangioblastomas are rare benign tumors that most commonly occur in the cerebellum and represent the third most common intramedullary spinal cord tumor (Fig. 14). They are associated with Von Hippel Lindau syndrome (VHL), particularly when seen within the cord, or if multiple lesions are detected. They are thought to arise from undifferentiated mesenchymal cells and are composed of densely packed capillaries lined with endothelial cells. There is no gender predilection, and they most commonly arise in the thoracic cord followed by the cervical cord [21–23].
Astrocytoma
Intramedullary astrocytomas are most common in children and tend to occur more frequently in males (Fig. 15). They are likely to occur in the thoracic cord, followed by the cervical cord, involve multiple vertebral body levels and are infiltrative in nature. They are associated with neurofibromatosis type I. High-grade intramedullary astrocytomas are very rare, though glioblastoma multiforme has been reported, with which leptomeningeal involvement is commonly present [22–24].
Distinguishing intramedullary tumors
In intramedullary neoplasms, the length of involvement, location along the cord, and enhancement pattern are the most helpful in narrowing the differential diagnosis (Table 3). Spinal cord astrocytomas will involve a long segment, as will (but to a lesser extent) ependymomas, while hemangioblastomas and metastases typically involve short segments. The enhancement pattern is essential in differentiating these lesions. In ependymoma, a solid, mostly homogeneous pattern of enhancement is typical, while astrocytomas will exhibit more heterogeneous enhancement. Other distinguishing features of ependymoma include presence of tumoral and nontumoral cysts and identification of a “cap sign”, which is a rim of T2 hypointense hemosiderin secondary to associated hemorrhage that can occur in about one-third of cases [24]. More aggressive subtypes, such as the rare spinal cord glioblastoma multiforme, tend to exhibit areas of hemorrhage and non-uniform enhancement (Fig. 16). In hemangioblastomas, presence of a feeding vessel, detected as a flow void on T2-weighted images, and a focus of intense nodular enhancement are characteristic findings. When multiple and short segments of enhancement are involved, metastases should be considered (Fig. 17), and search for a primary malignancy should ensue if not already known.
Table 3.
Neoplastic lesions | Location | Length and segment distribution | Enhancement |
---|---|---|---|
Astrocytoma | Thoracic > cervical | 4–7 Vertebral bodies | Heterogeneous |
Ependymoma | Cervical > thoracic | 4 Vertebral bodies | Solid Heterogeneous |
Hemangioblastomas | Thoracic > cervical Eccentric, may be exophytic |
Short segment | Nodular Feeding vessel |
GBM | Nonspecific | Nonspecific | Irregular Heterogeneous |
Metastasis | Cervical > thoracic > lumbar | Multiple Several segments |
Small compared to extent of edema |
Vascular lesions
Dural arteriovenous fistulas
Dural arteriovenous fistulas (dAVF) are the most common spinal cord vascular malformation (Figs. 18 and 19). These lesions are composed of a direct communication between a nerve root sleeve dural artery and vein and are categorised as a type I spinal vascular malformation. They are usually diagnosed late because of their prevalence in the elderly male population and nonspecific symptomatology, which often overlap with those of spondylosis or polyneuropathy [25]. A common pattern of diagnosis is in those with post-laminectomy syndrome, who exhibit persistent symptoms after spinal surgery for spondylosis. Although digital subtraction angiography is the gold standard study for definitive diagnosis, MRI and magnetic resonance angiography (MRA) techniques have become increasingly more sensitive for detection of this rare, but important spinal pathology. On MRI, serpentine flow voids on the surface of the cord with engorged venous structures and intramedullary hyperintensity on T2-weighted sequences are reliable clues to the diagnosis [26, 27]. The condition should be considered in patients with insidious myelopathy, as it can be reversible if diagnosed and treated early in the course of the disease.
Arteriovenous malformations
Intramedullary spinal arteriovenous malformations (AVM) are significantly rarer than dAVFs, representing about 25% of vascular lesions within the spine. They can present as a spinal subdural hemorrhage or progressive myelopathy in which patients initially experience spastic paralysis followed by flaccid paralysis of the extremities, accompanied by sensory deficits and sphincter dysfunction. This clinical presentation has been termed the Foix-Alanjouanine syndrome [28]. Spinal arteriovenous malformations contain a true arteriovenous capillary nidus fed by an enlarged feeding artery and drained via an enlarged venous plexus on the cord surface (Fig. 20). They are categorised as type II spinal vascular malformations and most commonly occur within the cervical or thoracic cord [28–31].
Cavernoma
Most commonly found in the thoracic cord, spinal cavernomas (also known as cavernous malformations) are rare lesions that commonly present intracranially. They consist of endothelial-lined lacunae filled with blood and surrounded by thick walls. They are occult on angiography as they do not communicate with the cord vasculature and have similar imaging characteristics as their intracranial counterparts [32, 33] (Fig. 21).
Infarct
Spinal cord infarctions occur very rarely, accounting for less than 1% of strokes. However, appropriate diagnosis of this entity is critical, as its symptoms overlap with other causes of myelopathy, such as demyelinating processes. There are many underlying aetiologies of spinal cord infarction, and they are classified according to the transverse involvement of the cord, which corresponds to the insulted vascular territory. MRI is the gold standard for diagnosis. All cases involve a long segment of the cord, and the majority of infarcts will involve the anterior spinal artery, resulting in anterior or central cord involvement [34] (Fig. 22).
Distinguishing vascular lesions
Segment length involvement is a very important distinguishing factor in spinal vascular lesions. Long-segment cord T2 hyperintensity should raise the suspicion of a dAVF or spinal cord infarct, while short segment involvement raises the possibility of a cavernoma or arteriovenous malformation. Cavernous malformations usually do not cause cord edema or expansion. “Popcorn-like” heterogeneity from blood products of differing ages, a hemosiderin perimeter (low T2 signal rim), and susceptibility or blooming on gradient echo sequences are classic findings. DAVFs almost always demonstrate T2 hyperintensity at the conus medullaris because of dependent cord edema, and identification of serpiginous flow voids on the surface of the cord is immensely helpful in making the diagnosis. This is in contrast to finding intramedullary serpentine flow voids and a short segment of intramedullary signal change, which should point to the presence of a nidus in an AVM. A long segment “owl-eye” appearance of bilateral ventral horn hyperintensity on T2-weighted images is concerning for the presence of anterior spinal artery infarction and should prompt a search for a possible underlying aetiology, such as severe atherosclerotic aortic disease, an aortic dissection or aneurysm (Table 4). Although rarely present, signal changes in the adjacent vertebral body manifesting as marrow edema or osseous infarction can be helpful in confirming the diagnosis of a spinal cord infarct [35].
Table 4.
Vascular lesions | Location | Length and segment distribution | Enhancement |
---|---|---|---|
Arteriovenous malformation | Dorsal Lower thoracic cord and conus medullaris |
Short segment | Heterogeneous, nodule of enhancement |
Dural arteriovenous fistula | Variable Edema of lower thoracic cord and conus |
Long segment | +/− Enhancement |
Cavernoma | Thoracic > cervical | Short segment | Minimal, heterogeneous |
Infarction | Depends on territory, anterior cord most common | Long segment | Depends on infarct age |
Miscellaneous
Compressive myelopathy
A common cause of weakness and sensory deficits in older patients is cervical compressive myelopathy or myelopathic spondylosis, which can occur secondary to spondylotic changes in the cervical spine and less commonly because of congenital abnormalities. The mechanism of injury involves decreased canal diameter and spinal stenosis, with resultant focal signal abnormality within the affected cord (Fig. 23). Ossification of the posterior longitudinal ligament (OPLL) is a common contributor. Compressive myelopathy typically demonstrates focal T2 hyperintensity in the cord at a level of spinal stenosis (at the level of a disc) with or without associated enhancement [36, 37] (Table 5).
Table 5.
Miscellaneous | Location | Length and segment distribution | Enhancement |
---|---|---|---|
Compressive myelopathy | At the disc level Cervical |
Focal, short segment | May see focal enhancement |
Hirayama disease | Anterior horns Cervical |
Long segment | May see enhancement of enlarged epidural space |
Hirayama disease
Hirayama disease is a disease of young males, mostly recognised in Japan and India. It presents with unilateral upper extremity weakness. The disease is related to a lax dura mater, which changes position with flexion and extension. Resulting repetitive circulatory changes in the anterior spinal artery due to cord compression cause atrophy and eventual necrosis in the anterior horns. MRI plays an essential role in the diagnosis of this rare disease (Fig. 24). Neutral cervical spine images are not very sensitive in showing the pertinent changes, and if there is clinical concern for this condition, flexion images should be obtained. Forward displacement of the dura mater is seen, with anterior cord compression and enlargement of the posterior epidural space, which may enhance post contrast. On transverse sections, there is atrophy of the anterior horns, which is typically asymmetric [38, 39] (Table 5).
Conclusion
As seen, there are myriad causes of abnormal signal within the spinal cord; demyelinating, metabolic, neoplastic, and vascular aetiologies must be considered when evaluating an abnormal cord. Although intramedullary spinal cord pathology can be a challenge, a systematic approach to imaging interpretation of these conditions focused on the length, location, and pattern of enhancement can greatly narrow the differential diagnosis, if not arrive at the correct diagnosis. This will not only add value to the care of the patient, but has the potential to prevent the use of more invasive methods of diagnosis.
Acknowledgements
We would like to acknowledge Nadezhda Kiriyak for creating illustrations for this publication and Margaret Kowaluk for figure formatting, both from the Digital Illustrations division at the University of Rochester, Department of Imaging Sciences.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Peh W. CT-guided percutaneous biopsy of spinal lesions. Biomed Imaging Interv J. 2006;2(3):e25. doi: 10.2349/biij.2.3.e25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Waxman SG. Clinical neuroanatomy. Twenty-seventh edition. Ed. New York: McGraw-Hill Education/Medical; 2013. [Google Scholar]
- 3.Diaz E, Morales H. Spinal cord anatomy and clinical syndromes. Semin Ultrasound CT MR. 2016;37(5):360–371. doi: 10.1053/j.sult.2016.05.002. [DOI] [PubMed] [Google Scholar]
- 4.Love S. Demyelinating diseases. J Clin Pathol. 2006;59(11):1151–1159. doi: 10.1136/jcp.2005.031195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Sarbu N, Shih RY, Jones RV, Horkayne-Szakaly I, Oleaga L, Smirniotopoulos JG. White matter diseases with radiologic-pathologic correlation. Radiographics. 2016;36(5):1426–1447. doi: 10.1148/rg.2016160031. [DOI] [PubMed] [Google Scholar]
- 6.Lövblad KO, Anzalone N, Dörfler A, Essig M, Hurwitz B, Kappos L, et al. MR imaging in multiple sclerosis: review and recommendations for current practice. AJNR Am J Neuroradiol. 2010;31(6):983–989. doi: 10.3174/ajnr.A1906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Lucchinetti CF, Guo Y, Popescu BF, Fujihara K, Itoyama Y, Misu T. The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol. 2014;24(1):83–97. doi: 10.1111/bpa.12099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Barnett Y, Sutton IJ, Ghadiri M, Masters L, Zivadinov R, Barnett MH. Conventional and advanced imaging in neuromyelitis optica. AJNR Am J Neuroradiol. 2014;35(8):1458–1466. doi: 10.3174/ajnr.A3592. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wingerchuk DM. Neuromyelitis optica spectrum disorders. Continuum (Minneap Minn) 2010;16(5 Multiple Sclerosis):105–121. doi: 10.1212/01.CON.0000389937.69413.15. [DOI] [PubMed] [Google Scholar]
- 10.Rossi A. Imaging of acute disseminated encephalomyelitis. Neuroimaging Clin N Am. 2008;18(1):149–161. doi: 10.1016/j.nic.2007.12.007. [DOI] [PubMed] [Google Scholar]
- 11.Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey AS, Kean MJ. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology. 2001;56(10):1308–1312. doi: 10.1212/WNL.56.10.1308. [DOI] [PubMed] [Google Scholar]
- 12.Alkan O, Yildirim T, Tokmak N, Tan M. Spinal MRI findings of Guillain-Barré syndrome. J Radiol Case Rep. 2009;3(3):25–28. doi: 10.3941/jrcr.v3i3.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Li HF, Ji XJ. The diagnostic, prognostic, and differential value of enhanced MR imaging in Guillain-Barre syndrome. AJNR Am J Neuroradiol. 2011;32(7):E140. doi: 10.3174/ajnr.A2620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Harzheim M, Schlegel U, Urbach H, Klockgether T, Schmidt S. Discriminatory features of acute transverse myelitis: a retrospective analysis of 45 patients. J Neurol Sci. 2004;217(2):217–223. doi: 10.1016/j.jns.2003.10.009. [DOI] [PubMed] [Google Scholar]
- 15.de Seze J, Lanctin C, Lebrun C, Malikova I, Papeix C, Wiertlewski S, et al. Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology. 2005;65(12):1950–1953. doi: 10.1212/01.wnl.0000188896.48308.26. [DOI] [PubMed] [Google Scholar]
- 16.Di Rocco A. HIV myelopathy. Handb Clin Neurol. 2007;85:123–128. doi: 10.1016/S0072-9752(07)85008-1. [DOI] [PubMed] [Google Scholar]
- 17.Chong J, Di Rocco A, Tagliati M, Danisi F, Simpson DM, Atlas SW. MR findings in AIDS-associated myelopathy. AJNR Am J Neuroradiol. 1999;20(8):1412–1416. [PMC free article] [PubMed] [Google Scholar]
- 18.Dutra BG, da Rocha AJ, Nunes RH, Maia ACM. Neuromyelitis optica spectrum disorders: Spectrum of MR imaging findings and their differential diagnosis. Radiographics. 2018;38(1):169–193. doi: 10.1148/rg.2018170141. [DOI] [PubMed] [Google Scholar]
- 19.Vide AT, Marques AM, Costa JD. MRI findings in subacute combined degeneration of the spinal cord in a patient with restricted diet. Neurol Sci. 2012;33(3):711–713. doi: 10.1007/s10072-011-0810-2. [DOI] [PubMed] [Google Scholar]
- 20.Rimbot A, Juglard R, Stéphant E, Bernard C, Aczel F, Talarmin B, et al. Subacute combined degeneration of the spinal cord: contribution of MRI. J Radiol. 2004;85(3):326–328. doi: 10.1016/S0221-0363(04)97586-5. [DOI] [PubMed] [Google Scholar]
- 21.Sun B, Wang C, Wang J, Liu A. MRI features of intramedullary spinal cord ependymomas. J Neuroimaging. 2003;13(4):346–351. doi: 10.1111/j.1552-6569.2003.tb00202.x. [DOI] [PubMed] [Google Scholar]
- 22.Koeller KK, Rosenblum RS, Morrison AL. Neoplasms of the spinal cord and filum terminale: radiologic-pathologic correlation. Radiographics. 2000;20(6):1721–1749. doi: 10.1148/radiographics.20.6.g00nv151721. [DOI] [PubMed] [Google Scholar]
- 23.Samartzis D, Gillis CC, Shih P, O'Toole JE, Fessler RG. Intramedullary spinal cord tumors: part I-epidemiology, pathophysiology, and diagnosis. Global Spine J. 2015;5(5):425–435. doi: 10.1055/s-0035-1549029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kim DH, Kim JH, Choi SH, Sohn CH, Yun TJ, Kim CH, et al. Differentiation between intramedullary spinal ependymoma and astrocytoma: comparative MRI analysis. Clin Radiol. 2014;69(1):29–35. doi: 10.1016/j.crad.2013.07.017. [DOI] [PubMed] [Google Scholar]
- 25.Jellema K, Tijssen CC, van Gijn J. Spinal dural arteriovenous fistulas: a congestive myelopathy that initially mimics a peripheral nerve disorder. Brain. 2006;129(Pt 12):3150–3164. doi: 10.1093/brain/awl220. [DOI] [PubMed] [Google Scholar]
- 26.Lee J, Lim YM, Suh DC, Rhim SC, Kim SJ, Kim KK. Clinical presentation, imaging findings, and prognosis of spinal dural arteriovenous fistula. J Clin Neurosci. 2016;26:105–109. doi: 10.1016/j.jocn.2015.06.030. [DOI] [PubMed] [Google Scholar]
- 27.Morris JM. Imaging of dural arteriovenous fistula. Radiol Clin N Am. 2012;50(4):823–839. doi: 10.1016/j.rcl.2012.04.011. [DOI] [PubMed] [Google Scholar]
- 28.Telarović S, Sarac H, Zagar M, Markeljević J, Vranjes D, Rados M. Coexistence of intradural spinal arteriovenous malformation and associated developmental anomalies—report of two cases. Coll Antropol. 2011;35(Suppl 1):319–325. [PubMed] [Google Scholar]
- 29.Zozulya YP, Slin'ko EI, Al-Qashqish II. Spinal arteriovenous malformations: new classification and surgical treatment. Neurosurg Focus. 2006;20(5):E7. doi: 10.3171/foc.2006.20.5.8. [DOI] [PubMed] [Google Scholar]
- 30.Krings T. Vascular malformations of the spine and spinal cord*: anatomy, classification, treatment. Clin Neuroradiol. 2010;20(1):5–24. doi: 10.1007/s00062-010-9036-6. [DOI] [PubMed] [Google Scholar]
- 31.Minami S, Sagoh T, Nishimura K, Yamashita K, Fujisawa I, Noma S, et al. Spinal arteriovenous malformation: MR imaging. Radiology. 1988;169(1):109–115. doi: 10.1148/radiology.169.1.3420244. [DOI] [PubMed] [Google Scholar]
- 32.Chabert E, Morandi X, Carney MP, Riffaud L, Louail C, Carsin-Nicol B. Intramedullary cavernous malformations. J Neuroradiol. 1999;26(4):262–268. [PubMed] [Google Scholar]
- 33.Tong X, Deng X, Li H, Fu Z, Xu Y. Clinical presentation and surgical outcome of intramedullary spinal cord cavernous malformations. J Neurosurg Spine. 2012;16(3):308–314. doi: 10.3171/2011.11.SPINE11536. [DOI] [PubMed] [Google Scholar]
- 34.Vargas MI, Gariani J, Sztajzel R, Barnaure-Nachbar I, Delattre BM, Lovblad KO, et al. Spinal cord ischemia: practical imaging tips, pearls, and pitfalls. AJNR Am J Neuroradiol. 2015;36(5):825–830. doi: 10.3174/ajnr.A4118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Suzuki T, Kawaguchi S, Takebayashi T, Yokogushi K, Takada J, Yamashita T. Vertebral body ischemia in the posterior spinal artery syndrome: case report and review of the literature. Spine (Phila Pa 1976) 2003;28(13):E260–E264. doi: 10.1097/01.BRS.0000067285.39466.FB. [DOI] [PubMed] [Google Scholar]
- 36.Young WF. Cervical spondylotic myelopathy: a common cause of spinal cord dysfunction in older persons. Am Fam Physician. 2000;62(5):1064–1070. [PubMed] [Google Scholar]
- 37.Al-Mefty O, Harkey LH, Middleton TH, Smith RR, Fox JL. Myelopathic cervical spondylotic lesions demonstrated by magnetic resonance imaging. J Neurosurg. 1988;68(2):217–222. doi: 10.3171/jns.1988.68.2.0217. [DOI] [PubMed] [Google Scholar]
- 38.Salome M, Barkhof F, Visser L (2017) Hirayama disease; an atypical clinical manifestation of a cervical myelopathy with typical MRI features. BMJ Case Rep 2017 [DOI] [PMC free article] [PubMed]
- 39.Lehman VT, Luetmer PH, Sorenson EJ, Carter RE, Gupta V, Fletcher GP, et al. Cervical spine MR imaging findings of patients with Hirayama disease in North America: a multisite study. AJNR Am J Neuroradiol. 2013;34(2):451–456. doi: 10.3174/ajnr.A3277. [DOI] [PMC free article] [PubMed] [Google Scholar]